Signaling pathways
-
BA3005 MirodenafilSummary: Mirodenafil (SK3530) is an orally effective, reversible, selective inhibitor of phosphodiesterase 5. -
BA3006 FimasartanSummary: Fimasartan (BR-A-657) is an angiotensin receptor AT1 nonpeptide antagonist. - BA3007 MPT0B392Summary: MPT0B392 is an orally active quinoline derivative that is an activator.
- BA3008 Thalidomide-O-C8-COOHSummary: Thalidomide-O-C8-COOH is a Thalidomide-based, ligand that recruits CRBN proteins.
- BA3009 WYC-209Summary: WYC-209, a synthetic retinoid, is a retinoic acid receptor agonist.
- BA3010 ASK1-IN-2Summary: ASK1-IN-2 is a potent, orally active inhibitor of apoptosis signal-regulated kinase 1.
- BA3011 SC99Summary: SC99 is an orally potent, selective inhibitor targeting the JAK2-STAT3 pathway.
- BA3012 SU11652Summary: SU11652 is a potent tyrosine kinase receptor inhibitor.
- BA3013 FasnallSummary: Fasnall is a selective fatty acid synthase inhibitor.
- BA3014 FalcarindiolSummary: Falcarindiol is an orally active polyacetylene oxylate that activates and increases the expression of the cholesterol transporter protein ABCA1 in cells.